Published in Arch Ophthalmol on January 01, 2001
Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med (2007) 1.33
Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol (2012) 0.93
Medical management of human immunodeficiency virus infection. Indian J Ophthalmol (2008) 0.85
Visual field loss in patients with cytomegalovirus retinitis. Ophthalmology (2010) 0.83
Results of silicone oil removal in post-cytomegalovirus retinitis-related retinal detachment. J Ophthalmic Inflamm Infect (2012) 0.78
Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting. Am J Ophthalmol (2014) 0.77
Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology (2012) 0.76
The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis. Invest Ophthalmol Vis Sci (2014) 0.76
Role of bedside ultrasound in CMV retinitis: a case report. Case Rep Emerg Med (2012) 0.75
Lowering the limit: reducing the CD4 T-cell threshold for ophthalmic screening in patients with HIV in an ethnically diverse UK population. Clin Ophthalmol (2014) 0.75
Cytomegalovirus retinitis in acquired immunodeficiency syndrome patients: A problem worth giving attention to. Indian J Sex Transm Dis (2014) 0.75
The eye in sexually transmitted infections: a review of the ocular complications of venereal diseases. Int Ophthalmol (2012) 0.75
Cytomegaloviral retinitis-related retinal detachment: outcomes following vitrectomy in the developing world. Int Ophthalmol (2013) 0.75
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med (1997) 5.48
Azithromycin in control of trachoma. Lancet (1999) 4.32
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant (2006) 4.09
Effect of ultraviolet radiation on cataract formation. N Engl J Med (1988) 3.59
Trachoma: evaluation of a new grading scheme in the United Republic of Tanzania. Bull World Health Organ (1987) 3.48
The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (2001) 3.31
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma. N Engl J Med (2016) 2.89
Results at age 8 years of early intervention for low-birth-weight premature infants. The Infant Health and Development Program. JAMA (1997) 2.66
A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Invest Ophthalmol Vis Sci (1997) 2.64
Prevalence of glaucoma in a rural East African population. Invest Ophthalmol Vis Sci (2000) 2.50
Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med (1990) 2.49
Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol (1989) 2.45
Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol (2000) 2.45
Ocular involvement in chronic sarcoidosis. Am J Ophthalmol (1986) 2.41
Thalidomide for the treatment of chronic graft-versus-host disease. N Engl J Med (1992) 2.31
Prevalence and causes of vision loss in central Tanzania. Int Ophthalmol (1991) 2.02
The heritability of age-related cortical cataract: the twin eye study. Invest Ophthalmol Vis Sci (2001) 1.88
Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood (1989) 1.85
Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum (2001) 1.85
Evaluation of barriers to surgical compliance in the treatment of trichiasis. Int Ophthalmol (1998) 1.84
Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health (1996) 1.80
Risk factors for brain tumors in children. Am J Epidemiol (1979) 1.80
Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group. J Infect Dis (1998) 1.80
Visual and medical risk factors for motor vehicle collision involvement among older drivers. Br J Ophthalmol (2008) 1.79
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol (1995) 1.76
Long term outcome of trichiasis surgery in the Gambia. Br J Ophthalmol (2005) 1.73
Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology (2000) 1.70
Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol (2000) 1.70
Eye care utilization by older Americans: the SEE Project. Salisbury Eye Evaluation. Ophthalmology (1999) 1.69
Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group. Arch Ophthalmol (1996) 1.66
Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). Ophthalmology (1989) 1.66
The association of multiple visual impairments with self-reported visual disability: SEE project. Invest Ophthalmol Vis Sci (2001) 1.64
Corneal changes associated with chronic UV irradiation. Arch Ophthalmol (1989) 1.59
Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol (1986) 1.56
The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol (1989) 1.53
The eye in bone marrow transplantation. VI. Retinal complications. Arch Ophthalmol (1994) 1.51
The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol (1983) 1.51
Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. Antimicrob Agents Chemother (1998) 1.49
Blindness and visual impairment in the Americas and the Caribbean. Br J Ophthalmol (2002) 1.44
Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy. Am J Ophthalmol (2000) 1.41
Monocular versus binocular visual acuity as measures of vision impairment and predictors of visual disability. Invest Ophthalmol Vis Sci (2000) 1.41
New treatments for anterior uveitis. Ophthalmology (1996) 1.39
A comparison of pulmonary function in male smokers and nonsmokers. Am Rev Respir Dis (1976) 1.39
Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy. Am J Ophthalmol (1991) 1.39
Laparoscopic cholecystectomy. N Z Med J (1996) 1.38
Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci (1997) 1.37
The impact of marital status on survival after an acute myocardial infarction: a population-based study. Am J Epidemiol (1983) 1.37
Ocular and facial skin exposure to ultraviolet radiation in sunlight: a personal exposure model with application to a worker population. Health Phys (1991) 1.37
Characteristics of discrepancies between self-reported visual function and measured reading speed. Salisbury Eye Evaluation Project Team. Invest Ophthalmol Vis Sci (1999) 1.35
Trichiasis and disability in a trachoma-endemic area of Tanzania. Arch Ophthalmol (2001) 1.33
Long term results of glaucoma surgery among participants in an east African population survey. Br J Ophthalmol (2000) 1.32
Risk factors for trachoma: 6-year follow-up of children aged 1 and 2 years. Am J Epidemiol (2000) 1.32
Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med (1985) 1.28
Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol (1991) 1.28
Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol (1991) 1.28
A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci (1990) 1.26
Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium. Neurogastroenterol Motil (2012) 1.25
Prevalence and risk factors for trachoma and ocular Chlamydia trachomatis infection in Niger. Br J Ophthalmol (2006) 1.25
Microvascular aspects of acquired immune deficiency syndrome retinopathy. Am J Ophthalmol (1984) 1.25
Early educational intervention for very low birth weight infants: results from the Infant Health and Development Program. J Pediatr (1993) 1.25
Pars planitis: clinical features and class II HLA associations. Ophthalmology (1999) 1.22
Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci (2001) 1.21
Summary of the II International Symposium on Cytomegalovirus. Antiviral Res (1998) 1.21
Ultraviolet light exposure and risk of posterior subcapsular cataracts. Arch Ophthalmol (1989) 1.21
Factors affecting attrition in a longitudinal study of patients with AIDS. AIDS Care (2006) 1.19
The clinical grading of lens opacities. Aust N Z J Ophthalmol (1989) 1.16
Secondary structure characterization of beta-lactamase inclusion bodies. Protein Eng (1994) 1.16
Syphilitic uveitis in human immunodeficiency virus-infected patients. Arch Ophthalmol (1997) 1.14
Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol (1996) 1.12
Cytomegalovirus retinitis in HIV-infected patients with elevated CD4+ counts. Arch Ophthalmol (1995) 1.12
Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther (2013) 1.12
Epidemiology of age-related macular degeneration. Mol Vis (1999) 1.11
Results of ophthalmic examinations of 29 alpacas. J Am Vet Med Assoc (1995) 1.10
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med (1998) 1.09
Comparison of respondents and nonrespondents in a periodic health examination program to a mailed questionnaire. Am J Public Health Nations Health (1966) 1.08
Presumed varicella zoster retinitis in immunocompromised patients. Retina (1987) 1.08
Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology (1994) 1.08
Regression of cytomegalovirus retinitis with zidovudine. A clinicopathologic correlation. Arch Ophthalmol (1989) 1.07
Characteristics of trichiasis patients presenting for surgery in rural Ethiopia. Br J Ophthalmol (2005) 1.07
Improved visual results after surgical repair of cytomegalovirus-related retinal detachments. Ophthalmology (1994) 1.07
The association between epilation and corneal opacity among eyes with trachomatous trichiasis. Br J Ophthalmol (2006) 1.07
Optic neuropathy in systemic lupus erythematosus. Arch Ophthalmol (1986) 1.06
AIDS and ophthalmology: a period of transition. Am J Ophthalmol (1997) 1.06
Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. Am J Ophthalmol (1998) 1.06
Examination methods for glaucoma prevalence surveys. Arch Ophthalmol (1993) 1.05
The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol (1983) 1.05
Testing a participatory strategy to change hygiene behaviour: face washing in central Tanzania. Trans R Soc Trop Med Hyg (1995) 1.04
Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group. Arch Ophthalmol (1996) 1.03
Recruitment in the Hypertension Prevention trial. Hypertension Prevention Trial Research Group. Control Clin Trials (1989) 1.03
Increased risk of brain tumors in children exposed to barbiturates. J Natl Cancer Inst (1978) 1.03
Drug utilization review in an HMO. I. Introduction and examples of methodology. Med Care (1977) 1.02